Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ACADIA Pharmaceuticals Inc. (ACAD) vs NetApp Inc. (NTAP) Price & Performance

ACADIA Pharmaceuticals Inc.Trade
NetApp Inc.Trade

Price performance (Past 24H)

Key statistics

ACADIA Pharmaceuticals Inc. vs NetApp Inc. — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while NetApp Inc. trades at $199.47 (market cap $38.95B). The key difference: NetApp Inc. is far larger — about 7.7× ACADIA Pharmaceuticals Inc.'s market cap, and NetApp Inc. pays a 1.05% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.

ACADNTAP
Market Cap
$5.07B$38.95B
Sector
HealthTechnology
52-Week High
$29.41$198.72
52-Week Low
$20.06$94.11
Enterprise Value
$4.19B$38.10B
Dividend Yield
1.05%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Read more on ACAD

About NetApp Inc.

NetApp is a leading provider of enterprise data management and storage solutions. The company's three operating business units are products, software maintenance, and hardware maintenance. NetApp transitioned from a data center storage firm to a company with software data management solutions for multicloud environments. The California-headquartered company sells globally and has approximately 10,000 employees.

Read more on NTAP